For insurers that have made big bets on managing government-subsidised health insurance programmes, the changes could not come at a worst time.<\/p>\n
![\"Bar](\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/07\/https:\/\/d6c748xw2pzm8.cloudfront.net\/prod\/2ee4f5d0-5cd2-11f0-bb34-3df6e0e23d52-standard.png\")
<\/p>\n
After several years of outsized growth as premiums far exceeded medical outlays, health insurers have suffered a reversal. Costs are rising as people, particularly seniors, come back for procedures put off during the pandemic. At the same time, federal payments for Medicare Advantage \u2014 private Medicare plans run by insurance companies that are mainly funded by the government \u2014 have dropped after the Biden administration clamped down on costs.\u00a0<\/p>\n
At UnitedHealth Group, net income fell more than a third last year. In May, it suspended its 2025 guidance on higher than expected medical costs for Medicare Advantage plans \u2014 an area in which it has expanded aggressively. The shares have shed half their value since April.<\/p>\n
Fellow insurer Centene last week pulled its full-year guidance while this week, Molina Healthcare lowered its outlook. The two, which generate more than three quarters of revenues from Medicaid and other government healthcare programs, cited rising medical costs. Their shares have slumped 43 per cent and 25 per cent respectively over the past week.\u00a0<\/p>\n
Trump\u2019s new legislation, by shrinking and further changing the health and cost profile of the enrollee pool, will only add to the pressure. In theory, insurers can raise premiums next year to offset the rising costs. In practice, higher premiums will probably drive healthier people to drop their insurance while those who remain would have more serious conditions \u2014 costing more to treat in a form of adverse selection. <\/p>\n
![\"Line](\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/07\/https:\/\/d6c748xw2pzm8.cloudfront.net\/prod\/144edc20-5cd4-11f0-b1a7-974c0ed416f9-standard.png\")
<\/p>\n
The government has been the big driver behind insurers\u2019 stock gains for many years but the gold rush is over. Instead, insurers that have historically underperformed because of their lack of exposure to government work are getting their moment in the sun. Cigna, which sold its small Medicare business to focus on the commercial insurance market, is up 13 per cent this year. Humana and Elevance Health, which have scaled back their exposure to the Medicare, have suffered far smaller declines than UnitedHealth and its rivals. With the exception of Cigna, big insurers are trading below their long-term average valuations. Consolidation could be the most attractive outcome for investors from an ugly situation.<\/p>\n